Buprenorphine: A unique opioid with broad clinical applications
Abstract
Keywords
Full Text:
PDFReferences
Umbricht A, Montoya ID, Hoover DR, et al.: Naltrexone shortened opioid detoxification with buprenorphine. Drug Alcohol Depend. 1999; 56(3): 181-190.
O’Connor PG, Fiellin DA: Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000; 133(1): 40-54.
Inagaki Y, Mashimo T, Yoshiya I: Mode and site of analgesic action of epidural buprenorphine in humans. Anesth Analg. 1996; 83(3): 530-536.
Cowan A: Buprenorphine: New pharmacological aspects. Int J Clin Pract Suppl. 2003; (133): 3-8, discussion 23-24.
Capogna G, Celleno D, Tagariello V, et al.: Intrathecal buprenorphine for postoperative analgesia in the elderly patient. Anaesthesia. 1988; 43(2): 128-130.
Celleno D, Capogna G: Spinal buprenorphine for postoperative analgesia after caesarean section. Acta Anaesthesiol Scand. 1989; 33(3): 236-238.
Dickenson AH, Sullivan AF, McQuay HJ: Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurones in the rat. Pain. 1990; 42(2): 227-234.
Schmauss C, Yaksh TL, Shimohigashi Y, et al.: Differential association of spinal mu, delta and kappa opioid receptors with cutaneous thermal and visceral chemical nociceptive stimuli in the rat. Life Sci. 1983; 33 Suppl 1: 653-656.
Collins ED, Kleber HD, Whittington RA, et al.: Anesthesia- ssisted vs. buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial. JAMA. 2005; 294(8): 903-913.
Gilbert AK, Franklin KB: The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats. Eur JPharmacol. 2002; 449(1-2): 75-84.
Umehara K, Shimokawa Y, Miyamoto G: Inhibition of human drug metabolizing cytochrome P450 by buprenorphine. Biol Pharm Bull. 2002; 25(5): 682-685.
Robinson SE: Buprenorphine: An analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev. 2002; 8(4): 377-390.
Ohtani M, Kotaki H, Sawada Y, et al.: Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther. 1995; 272(2): 505-510.
Villiger JW, Boas RA, Taylor KM: A radioreceptor assay for opiate drugs in human cerebrospinal fluid and plasma. Life Sci. 1981; 29(3): 229-233.
Bennett G, Serafini M, Burchiel K, et al.: Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage. 2000; 20(2): S12-S36.
Sanchez-Blazquez P, Gomez-Serranillos P, Garzon J: Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. Brain Res Bull. 2001; 54(2): 229-235.
Tejwani GA, Rattan AK: The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat. Anesth Analg. 2002; 94(6): 1542-1546, table of contents.
Negus SS, Bidlack JM, Mello NK, et al.: Delta opioid antagonist effects of buprenorphine in rhesus monkeys. Behav Pharmacol. 2002; 13(7): 557-570.
Benedict PE, Benedict MB, Su TP, et al.: Opiate drugs and delta-receptor-mediated myocardial protection. Circulation. 1999; 100(19 Suppl.): 11357-11360.
Bloms-Funke P, Gillen C, Schuettler AJ, et al.: Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor. Peptides. 2000; 21(7): 1141-1146.
Mehta Y, Juneja R, Madhok H, et al.: Lumbar versus thoracic epidural buprenorphine for postoperative analgesia following coronary artery bypass graft surgery. Acta Anaesthesiol Scand. 1999; 43(4): 388-393.
Roughan JV, Flecknell PA: Buprenorphine: A reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab Anim. 2002; 36(3): 322-343.
Lanz E, Simko G, Theiss D, et al.: Epidural buprenorphine— a double-blind study of postoperative analgesia and side effects. Anesth Analg. 1984; 63(6): 593-598.
Miwa Y, Yonemura E, Fukushima K: Epidural administered buprenorphine in the perioperative period. Can J Anaesth. 1996; 43(9): 907-913.
Giebler RM, Scherer RU, Peters J: Incidence of neurologic complications related to thoracic epidural catheterization. Anesthesiology. 1997; 86(1): 55-63.
Govindarajan R, Bakalova T, Michael R, et al.: Epidural buprenorphine in management of pain in multiple rib fractures. Acta Anaesthesiol Scand. 2002; 46(6): 660-665.
Hirabayashi Y, Mitsuhata H, Shimizu R, et al.: [Continuous epidural buprenorphine for postoperative pain relief in patients after lower abdominal surgery]. Masui. 1993; 42(11): 1618-1622.
Takata T, Yukioka H, Fujimori M: [Epidural morphine and buprenorphine for postoperative pain relief after hepatectomy]. Masui. 1990; 39(1): 13-18.
Kamal RS, Khan FA: Caudal analgesia with buprenorphine for postoperative pain relief in children. Paediatr Anaesth. 1995; 5(2): 101-106.
Girotra S, Kumar S, Rajendran KM: Postoperative analgesia in children who have genito-urinary surgery. A comparison between caudal buprenorphine and bupivacaine. Anaesthesia. 1990; 45(5): 406-408.
Girotra S, Kumar S, Rajendran KM: Comparison of caudal morphine and buprenorphine for post-operative analgesia in children. Eur J Anaesthesiol. 1993; 10(4): 309-312.
Batra YK, Gill PK, Vaidyanathan S, et al.: Effect of epidural buprenorphine and clonidine on vesical functions in women. Int J Clin Pharmacol Ther. 1996; 34(7): 309-311.
Kaetsu H, Takeshi M, Chigusa S, et al.: [Analgesic effects of epidurally administered fentanyl for postoperative pain relief— comparison with buprenorphine]. Masui. 1992; 41(12): 1870-1874.
Dahm P, Lundborg C, Janson M, et al.: Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: Results from a prospective, crossover, double-blind, randomized study. Reg Anesth Pain Med. 2000; 25(5): 480-487.
Abrahamsson J, Niemand D, Olsson AK, et al.: [Buprenorphine (Temgesic) as a perioperative analgesic. A multicenter study]. Anaesthesist. 1983; 32(2): 75-79.
Ho ST, Wang JJ, Liu HS, et al.: The analgesic effect of PCA buprenorphine in Taiwan’s gynecologic patients. Acta Anaesthesiol Sin. 1997; 35(4): 195-199.
Beltrutti D, Niv D, Ben-Abraham R, et al.: Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans. J Clin Anesth. 2002; 14(6): 441-446.
Matsumoto S, Mitsuhata H, Akiyama H, et al.: [The effect of subcutaneous administration of buprenorphine with patientcontrolled analgesia system for post-operative pain relief]. Masui. 1994; 43(11): 1709-1713.
Bullingham RE, McQuay HJ, Dwyer D, et al.: Sublingual buprenorphine used postoperatively: Clinical observations and preliminary pharmacokinetic analysis. Br J Clin Pharmacol. 1981; 12(2): 117-122.
Tauzin-Fin P, Saumtally S, Houdek MC, et al.: [Analgesia by sublingual buprenorphine in extracorporeal kidney lithotripsy]. Ann Fr Anesth Reanim. 1993; 12(3): 260-264.
Gaitini L, Moskovitz B, Katz E, et al.: Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy. Urol Int. 1996; 57(4): 227-229.
Witjes WP, Crul BJ, Vollaard EJ, et al.: Application of sublingual buprenorphine in combination with naproxen or paracetamol for post-operative pain relief in cholecystectomy patients in a double-blind study. Acta Anaesthesiol Scand. 1992; 36(4): 323-327.
Fang JY, Hwang TL, Huang YB, et al.: Transdermal ion-tophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods. Int J Pharm. 2002; 235(1-2): 95-105.
Balint G: Buprenorphine treatment of patients with nonmalignant musculoskeletal diseases. Clin Rheumatol. 2002; 21 Suppl. 1: S17-S18.
Rodriguez NA, Cooper DM, Risdahl JM: Antinociceptive activity of and clinical experience with buprenorphine in swine. Contemp Top Lab Anim Sci. 2001; 40(3): 17-20.
Volker D, Bate M, Gentle R, et al.: Oral buprenorphine is anti-inflammatory and modulates the pathogenesis of streptococcal cell wall polymer-induced arthritis in the Lew/SSN rat. Lab Anim. 2000; 34(4): 423-429.
Varrassi G, Marinangeli F, Ciccozzi A, et al.: Intra-articular buprenorphine after knee arthroscopy. A randomised, prospective, double-blind study. Acta Anaesthesiol Scand. 1999; 43(1): 51-55.
Candido KD, Winnie AP, Ghaleb AH, et al.: Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia. Reg Anesth Pain Med. 2002; 27(2): 162-167.
Kouya PF, Hao JX, Xu XJ: Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury. Eur J Pharmacol. 2002; 450(1): 49-53.
Wheeler-Aceto H, Cowan A: Buprenorphine and morphine cause antinociception by different transduction mechanisms. Eur J Pharmacol. 1991; 195(3): 411-413.
Malinoff HL, Barkin RL, Wilson G: Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005; 12(5): 379-384.
Koppert W, Ihmsen H, Korber N, et al.: Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain. 2005; 118(1-2): 15-22.
Kreek MJ, Vocci FJ: History and current status of opioid maintenance treatments: Blending conference session. JSubst Abuse Treat. 2002; 23(2): 93-105.
Walsh SL, Preston KL, Stitzer ML, et al.: Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther. 1994; 55(5): 569-580.
Mattick RP, Kimber J, Breen C, et al.: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2002; (4): CD002207.
Seifert J, Metzner C, Paetzold W, et al.: Detoxification of opiate addicts with multiple drug abuse: A comparison of buprenorphine vs. methadone. Pharmacopsychiatry. 2002; 35(5): 159-164.
Unknown author: Narcotics scheduling. Federal Register. 2002; 67: 62354-62370.
Breen CL, Harris SJ, Lintzeris N, et al.: Cessation of methadone maintenance treatment using buprenorphine: Transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend. 2003; 71(1): 49-55.
Kutz I, Reznik V: Heroin detoxification with a single high dose of buprenorphine. Isr J Psychiatry Relat Sci. 2002; 39(2): 113-119.
Deshmukh SV, Nanovskaya TN, Ahmed MS: Aromatase is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther. 2003; 306(3): 1099-1105.
Davis MP: Buprenorphine in cancer pain. Support Care Cancer. 2005; 13(11): 878-887.
Alford DP, Compton P, Samet JH: Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006; 144(2): 127-134.
Johnson RE, Fudala PJ, Payne R: Buprenorphine: Considerations for pain management. J Pain Symptom Manage. 2005; 29(3): 297-326.
Fultz JM, Senay EC: Guidelines for the management of hospi-talized narcotics addicts. Ann Intern Med. 1975; 82(6): 815-818.
Harcus AH, Ward AE, Smith DW: Buprenorphine in postop-erative pain: Results in 7500 patients. Anaesthesia. 1980; 35(4): 382-386.
Yasuda S, Hiyama A, Shigematsu T, et al.: [Comparison of intravenous buprenorphine or fentanyl and epidural buprenorphine for pain relief after upper abdominal surgery]. Masui. 1990; 39(4): 487-490.
Seet RC, Lim EC: Intravenous use of buprenorphine tablets associated with rhabdomyolysis and compressive sciatic neuropathy. Ann Emerg Med. 2006; 47(4): 396-397.
de Stoutz ND, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. 1995; 10(5): 378-384.
Soyka M, Hock B, Kagerer S, et al.: Less impairment on one portion of a driving-relevant psychomotor battery in buprenor- phine-maintained than in methadone-maintained patients: Results of a randomized clinical trial. J Clin Psychopharmacol. 2005; 25(5): 490-493.
Criado AB, Gomez de Segura IA, Tendillo FJ, et al.: Reduction of isoflurane MAC with buprenorphine and morphine in rats. Lab Anim. 2000; 34(3): 252-259.
Hedenqvist P, Roughan JV, Flecknell PA: Effects of repeated anaesthesia with ketamine/medetomidine and of pre-anaesthetic administration of buprenorphine in rats. Lab Anim. 2000; 34(2): 207-211.
DOI: https://doi.org/10.5055/jom.2007.0038
Refbacks
- There are currently no refbacks.